Translation from the data of clinical trials to precision medicine: limitation of the current risk score for predicting coronary thrombosis and major bleeding

about

Translation from the data of clinical trials to precision medicine: limitation of the current risk score for predicting coronary thrombosis and major bleeding

Item

http://www.wikidata.org/entity/Q42384622

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Translation from the data of c ...... thrombosis and major bleeding

@en

Translation from the data of c ...... thrombosis and major bleeding

@nl

type

Item

label

Translation from the data of c ...... thrombosis and major bleeding

@en

Translation from the data of c ...... thrombosis and major bleeding

@nl

prefLabel

Translation from the data of c ...... thrombosis and major bleeding

@en

Translation from the data of c ...... thrombosis and major bleeding

@nl

P1476

Translation from the data of c ...... thrombosis and major bleeding

@en

P2093

Jeong Yoon Jang

http://www.w3.org/2001/XMLSchema#string

Jong-Hwa Ahn

http://www.w3.org/2001/XMLSchema#string

Young-Hoon Jeong

http://www.w3.org/2001/XMLSchema#string

P2860

Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Review of the Evidence

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents

Arterial thrombus formation in cardiovascular disease.

Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI.

Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial.

Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.

Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention.

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.

A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome

P304

2376-2378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/JTD.2016.09.22

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27746980

http://www.w3.org/2001/XMLSchema#string

P921

thrombosis

P932

5059355

http://www.w3.org/2001/XMLSchema#string